Paper1907623
Chronic exposure to glibenclamide impairs insulin secretion in isolated rat pancreatic islets.
Gullo D and 7 others. J Endocrinol Invest, 1991. Cited by 15 papers, by iCite.
Cite this record
ConductScience Library. Chronic exposure to glibenclamide impairs insulin secretion in isolated rat pancreatic islets. Papers, record 1907623. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/1907623
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Chronic exposure to glibenclamide impairs insulin secretion in isolated rat pancreatic islets.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Glyburide | Major topic |
| Insulin | Major topic |
| Islets of Langerhans | Major topic |
| Animals | |
| In Vitro Techniques | |
| Insulin Secretion | |
| Male | |
| Rats | |
| Rats, Inbred Strains | |
| Time Factors | |
| Tolbutamide |
Source PubMed
References21
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 6759232 | Insulin responses to nonglucose stimuli in non-insulin-dependent diabetes mellitus during a tolbutamide infusion. | Diabetes | 1982 | https://conductscience.org/library/papers/6759232 | PubMed |
| 2 | 4209518 | An inhibitory effect of tolbutamide and glibenclamide (glyburide) on the pancreatic islets of normal animals. | Diabetologia | 1974 | https://conductscience.org/library/papers/4209518 | PubMed |
| 3 | 6760195 | Glucose-induced insulin release depends on functional cooperation between islet cells. | Proc Natl Acad Sci U S A | 1982 | https://conductscience.org/library/papers/6760195 | PubMed |
| 4 | 6428844 | Oral sulfonylurea agents suppress hepatic glucose production in non-insulin-dependent diabetic individuals. | Diabetes Care | 1984 | https://conductscience.org/library/papers/6428844 | PubMed |
| 5 | 783201 | Arginine-stimulated acute phase of insulin and glucagon secretion in diabetic subjects. | J Clin Invest | 1976 | https://conductscience.org/library/papers/783201 | PubMed |
| 6 | 2839387 | Interaction of sulfonylureas with pancreatic beta-cells. A study with glyburide. | Diabetes | 1988 | https://conductscience.org/library/papers/2839387 | PubMed |
| 7 | 3123184 | Comparison of pharmacokinetics, metabolic effects and mechanisms of action of glyburide and glipizide during long-term treatment. | Diabetes Care | 1987 | https://conductscience.org/library/papers/3123184 | PubMed |
| 8 | 6987025 | Effect of prolonged glyclazide treatment on blood glucose and plasma insulin responses in obese patients with maturity-onset diabetes. | Clin Pharmacol Ther | 1980 | https://conductscience.org/library/papers/6987025 | PubMed |
| 9 | 3936738 | Sulphonylurea therapy doubles B-cell response to glucose in type 2 diabetic patients. | Diabetologia | 1985 | https://conductscience.org/library/papers/3936738 | PubMed |
| 10 | 2452071 | Characteristics of desensitization of insulin secretion in fully in vitro systems. | Endocrinology | 1988 | https://conductscience.org/library/papers/2452071 | PubMed |
| 11 | 319321 | Onset and reversibility of changes in secretory function and composition of isolated rat pancreatic islets following long-term administrationof high or low tolbutamide doses. | Metabolism | 1977 | https://conductscience.org/library/papers/319321 | PubMed |
| 12 | 2422950 | In vitro exhaustion of pancreatic beta-cells. | Am J Physiol | 1986 | https://conductscience.org/library/papers/2422950 | PubMed |
| 13 | 2544404 | Phosphoinositide hydrolysis and insulin secretion in response to glucose stimulation are impaired in isolated rat islets by prolonged exposure to the sulfonylurea tolbutamide. | Endocrinology | 1989 | https://conductscience.org/library/papers/2544404 | PubMed |
| 14 | 2559866 | Effects of high glucose on insulin secretion by isolated rat islets and purified beta-cells and possible role of glycosylation. | Diabetes | 1989 | https://conductscience.org/library/papers/2559866 | PubMed |
| 15 | 2656336 | A new phase of insulin secretion. How will it contribute to our understanding of beta-cell function? | Diabetes | 1989 | https://conductscience.org/library/papers/2656336 | PubMed |
| 16 | 5052977 | Effect of chronic sulfonylurea therapy on plasma insulin and proinsulin levels. | J Clin Endocrinol Metab | 1972 | https://conductscience.org/library/papers/5052977 | PubMed |
| 17 | 6988275 | Tolbutamide stimulation and inhibition of insulin release: studies of the underlying ionic mechanisms in isolated rat islets. | Diabetologia | 1980 | https://conductscience.org/library/papers/6988275 | PubMed |
| 18 | 6988265 | Glipizide versus tolbutamide, an open trial. Effects on insulin secretory patterns and glucose concentrations. | Diabetologia | 1980 | https://conductscience.org/library/papers/6988265 | PubMed |
| 19 | 6139273 | Suppressive effect of long term sulfonylurea treatment on A, B, and D cells of normal rat pancreas. | Endocrinology | 1983 | https://conductscience.org/library/papers/6139273 | PubMed |
| 20 | 3533680 | Selective unresponsiveness of pancreatic beta-cells to acute sulfonylurea stimulation during sulfonylurea therapy in NIDDM. | Diabetes | 1986 | https://conductscience.org/library/papers/3533680 | PubMed |
Cited by6
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 15 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 36305868 | Multiplexed microfluidic platform for stem-cell derived pancreatic islet β cells. | Lab Chip | 2022 | https://conductscience.org/library/papers/36305868 | PubMed |
| 32069073 | Chronic stimulation induces adaptive potassium channel activity that restores calcium oscillations in pancreatic islets in vitro. | Am J Physiol Endocrinol Metab | 2020 | https://conductscience.org/library/papers/32069073 | PubMed |
| 19151370 | Sulfonylurea receptor 1 mutations that cause opposite insulin secretion defects with chemical chaperone exposure. | J Biol Chem | 2009 | https://conductscience.org/library/papers/19151370 | PubMed |
| 18959471 | Chronic antidiabetic sulfonylureas in vivo: reversible effects on mouse pancreatic beta-cells. | PLoS Med | 2008 | https://conductscience.org/library/papers/18959471 | PubMed |
| 18032110 | Drugs acting on SUR1 to treat CNS ischemia and trauma. | Curr Opin Pharmacol | 2008 | https://conductscience.org/library/papers/18032110 | PubMed |
| 10807689 | Induced desensitization of the insulinotropic effects of antidiabetic drugs, BTS 67 582 and tolbutamide. | Br J Pharmacol | 2000 | https://conductscience.org/library/papers/10807689 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/1907623
GET https://conductscience.org/api/papers/v1/1907623/references?page=2